- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Multiple Sclerosis in United Kingdom
Total 1670 results
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Canbex Therapeutics LtdCompletedSpasticity in People With Multiple SclerosisUnited Kingdom
-
The Royal Bournemouth HospitalUnknownPatients Requiring Diagnostic Gastroscopy With SedationUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Imperial College LondonGlaxoSmithKlineWithdrawnHealthy Smokers | Healthy Non-smokers | Patients With Mild Asthma | Patints With COPD (GOLD II)United Kingdom
-
London North West Healthcare NHS TrustSt Mark's FoundationCompletedPatients With Potential Colorectal NeoplasiaUnited Kingdom
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
Philogen S.p.A.TerminatedPatients With CancerItaly, United Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Glasgow Caledonian UniversityUnknown
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Daval International LimitedUnknownSecondary Progressive Multiple SclerosisUnited Kingdom
-
The Cleveland ClinicNational Institutes of Health (NIH)WithdrawnGait Disturbance in Multiple Sclerosis PatientsUnited States
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
Bristol-Myers SquibbCompleted
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
Queen Mary University of LondonBarts & The London NHS Trust; National Institute for Health Research, United... and other collaboratorsRecruitingProgressive Multiple Sclerosis | Advanced Multiple SclerosisUnited Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
Jazz PharmaceuticalsTerminatedSpasticity With Multiple SclerosisSpain, United States, United Kingdom, Czechia, Poland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Trio Medicines Ltd.BiogenCompleted
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
SanofiCompletedMultiple Sclerosis Healthy SubjectsUnited Kingdom